Therapeutic potential of FLT4-targeting peptide in acute myeloid leukemia
Ji Yoon Lee(Institute for Stem Cell Biology and Regenerative Medicine), Hee‐Je Kim(St. Mary's Hospital)
Cited by 0
Related Papers
Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin
|Carcinogenesis|2004|84
Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis
|Scientific Reports|2019|11
AML-432 Overall Survival (OS) by Mutant Allele (R140 or R172) in Patients With Late-Stage, Mutant- Relapsed/Refractory Acute Myeloid Leukemia (AML) Treated With Enasidenib or Conventional Care Regimens (CCR) in the Randomized, Open-Label, Phase 3 IDHENTIFY Trial
|Clinical Lymphoma Myeloma & Leukemia|2022|0